Log In

 

All News


Sort By News Date & Time News Source Sort Descending Order News Title

  Refine Search  
Keywords
Date Range
 
News Type
  India
  International

12/11/2012 9:10AM

ABRAXANE® Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study

Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that its phase III study of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) ...

25/10/2012 5:08PM

ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients

Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that abstracts for the upcoming Society for Melanoma Research meeting have been published online in the ...

03/03/2015 11:50AM

ABRAXANE® Approved by European Commission for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), announced that the European Commission (EC) has approved ABRAXANE® (paclitaxel formulated as albumin-bound ...

03/10/2012 10:40AM

ABRAXANE Meets Primary Endpoint of Progression-Free Survival in Phase III Chemotherapy-Naïve Metastatic Melanoma Study

Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) has announced results of its phase III, randomized, international study (CA033) of ABRAXANE® (paclitaxel ...

18/02/2016 5:11PM

ABP News CSR Leadership Award to Uflex for Outstanding Contribution to 'Sports for Growth'

India’s largest global flexible packaging company Uflex Limited has been honoured with ABP News CSR Leadership Award 2016 for its outstanding contribution through the intervention “Sports for Growth” ...

06/12/2016 3:43PM

ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and Efficacy of ABRAXANE® for Challenging Patient Populations

Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND clinical trial program evaluating the use of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) ...

06/10/2017 3:20PM Image

Abode1st Group will Provide the Suitable Real-estate Market to the Investors

The laws made by Central government to make the business and real estate sector accountable to the market are going to have a positive impact on the country's market. With this, the foreign investors have trusted the ...

05/11/2008 11:00AM

ABnote and Datacard Group Partner to Strengthen Critical NFC Technologies

ABnote and Datacard Group are pleased to introduce Redwave(TM) Solutions. Redwave Solutions combines the expertise of two world-class companies to create a global trusted service manager for the Near Field ...